Roivant's rare disease shop captures FDA designations; China biotech lands $18M launch round
→ Weeks after Alexion’s $ALXN Rachelle Jacques jumped ship to assume the role of CEO of Enzyvant Sciences — forged out of Vivek Ramaswamy’s prolific …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
